ストックスクリーナーアプリを入手
153.62
0.48%
-0.74
プレマーケット:
154.28
0.66
+0.43%
前日終値:
$154.36
開ける：
$155.7
24時間の取引高:
10.72M
Relative Volume:
1.13
時価総額：
$344.63B
収益：
$88.82B
当期純損益:
$14.07B
株価収益率:
26.53
EPS:
5.79
ネットキャッシュフロー:
$18.06B
1週間 パフォーマンス:
+2.41%
1か月 パフォーマンス:
-5.64%
6か月 パフォーマンス:
-6.39%
1年 パフォーマンス:
+4.09%
1日の値動き範囲:
$152.10
$156.30
1週間の範囲:
$141.50
$156.30
52週間の値動き範囲:
$140.68
$169.90
Johnson Johnson Stock (JNJ) Company Profile
名前
Johnson Johnson
セクター
電話
732-524-2455
住所
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
JNJ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
153.62 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
LLY
Lilly Eli Co
|
757.18 | 680.08B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
176.80 | 312.76B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
64.49 | 286.27B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
109.93 | 217.12B | 51.72B | 11.94B | 13.81B | 5.88 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-07-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-05-30 | 再開されました | Goldman | Neutral |
| 2024-04-18 | アップグレード | HSBC Securities | Hold → Buy |
| 2023-12-13 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-12-01 | アップグレード | UBS | Neutral → Buy |
| 2023-10-05 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-05-30 | 再開されました | Citigroup | Buy |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-01 | 開始されました | Guggenheim | Neutral |
| 2022-11-18 | 開始されました | Credit Suisse | Neutral |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-14 | 繰り返されました | BofA Securities | Neutral |
| 2022-06-22 | 開始されました | Daiwa Securities | Outperform |
| 2022-05-23 | 再開されました | SVB Leerink | Outperform |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-03-16 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-17 | 開始されました | Goldman | Neutral |
| 2021-12-15 | 繰り返されました | Citigroup | Buy |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-05-28 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-28 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-22 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-19 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-12-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-10-16 | アップグレード | Atlantic Equities | Underweight → Neutral |
| 2019-10-11 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2019-07-12 | 再開されました | Credit Suisse | Outperform |
| 2019-05-28 | 開始されました | Goldman | Buy |
| 2019-01-23 | 繰り返されました | Barclays | Equal Weight |
| 2018-07-12 | アップグレード | Goldman | Sell → Neutral |
| 2018-06-27 | 開始されました | Bernstein | Mkt Perform |
| 2018-04-23 | 繰り返されました | Citigroup | Neutral |
| 2018-04-18 | 繰り返されました | Stifel | Hold |
| 2018-01-24 | 繰り返されました | Stifel | Hold |
| 2018-01-12 | 繰り返されました | Wells Fargo | Outperform |
| 2018-01-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-10-18 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-10-18 | 繰り返されました | Stifel | Hold |
すべてを表示
Johnson Johnson (JNJ) 最新ニュース
Trump’s Tariff Threat for Drug imports Poses Big Political Risks - The New York Times
Obituary for Ken Johnson - Harvey Anderson & Johnson Funeral Home
The Atlantic Hires Jenna Johnson and Dan Zak as Senior Editors, and Tyler Austin Harper as Staff Writer - The Atlantic
Dow Giant Flexes With A Guidance Hike Despite Tariff Worries - Investor's Business Daily
Furr, Johnson Added Women’s Basketball Staff - Arkansas Razorbacks
Johnson & Johnson (JNJ): Stuck in a Range but Ready to Break Out if Legal Clouds Clear – Jim Cramer Weighs In - Yahoo Finance
Johnson & Johnson estimates $400M impact from worldwide tariffs, largely in medtech - Fierce Biotech
LEGACY IN FOCUS: Whitney Johnson, Women's Basketball - Morgan State University Athletics
Johnson & Johnson Earnings: Solid Innovation and Manageable Tariff Headwind - Morningstar
Johnson & Johnson expects $400M in tariff costs this year - MassDevice
Johnson and Johnson warns pharma tariffs could cause drug shortages - Financial Times
J&J pegs tariff costs at about $400M in 2025 - MedTech Dive
J&J beat on earnings, but tariffs still pressure pharma sector - Yahoo Finance
J&J completes first surgeries with Ottava robot - MedTech Dive
J&J keeps forecasts steady as pharma confronts tariff threat - BioPharma Dive
As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations - Fierce Pharma
Johnson & Johnson CEO warns US tariffs may disrupt drug supply - Reuters
Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China - Yahoo Finance
Why Johnson & Johnson Stock Is Down After Earnings Beat Expectations - Barron's
Digital Marketing Grad Makes Data-Driven Decisions at Johnson & Johnson - Full Sail University
Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit - Benzinga
Stocks making the biggest moves premarket: Bank of America, Boeing, Johnson & Johnson and more - CNBC
Johnson & Johnson Tops Earnings Estimates and Boosts Outlook. The Stock Slips. - Barron's
Johnson & Johnson Reports Q1 2025 Results - BioSpace
Tax policy key to building US manufacturing, says Johnson & Johnson CEO - MarketWatch
Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook - Investopedia
What you need to know about Johnson & Johnson’s 2025 first-quarter earnings - Johnson & Johnson
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8% - Yahoo Finance
J&J beats Wall Street quarterly sales and profit estimates on cancer drug sales - Yahoo Finance
The Rock to co-author true crime book about Hawaii mob boss to be adapted by Martin Scorsese - The Guardian
What I’m Hearing on Shedeur Sanders and Will Johnson. Plus, Offensive Line Tiers, Comps, and Tape Study. - The Ringer
Mike Johnson opens the door to Medicaid cuts and the resulting political fallout - MSN
Depot After Dark: Franco In College, Diontae Johnson Praises Big Ben, Steelers Germany Flag Football Camp - Steelers Depot
Rep. Josh Gottheimer Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat
Denison, Reigning D3 Men’s NCAA Champion, Add Nicholas Johnson For Fall 2025 - SwimSwam
Katilyn Johnson on Instagram - Instagram
McNeese signs Larry Johnson Jr. as hoops transfer - Crescent City Sports
Influencer Kayla Malec Accused Ex-Boyfriend Evan Johnson Of Domestic Violence - Her Campus
Auburn safety CJ Johnson plans to enter NCAA transfer portal - On3.com
The Human Side of Tech-Enabled HealthcareSponsor ContentJohnson & Johnson - The Atlantic
2025 Mock Draft Monday 10.0: Reinforcements Coming to the Offensive and Defensive Lines? - San Francisco 49ers
Jeffrey Edward "Jeff" Johnson Obituary (2025)Marshall, NCMadison Funeral Services - Legacy.com
Amy Johnson Obituary (19692025)Richwood, OHMarion County Now - Legacy.com
What's next for Spurs' Mitch Johnson? - San Antonio Express-News
Bank of America, Johnson & Johnson, Citigroup set to report Tuesday - Investing.com
Johnson & Johnson (JNJ) Stands Firm as Recession-Resistant Tariff-Proof Anchor - The Globe and Mail
House Speaker Mike Johnson raises more than $30 million in Q1 - Washington Examiner
No shortage of teams calling about Cameron Johnson trade - USA TODAY High School Sports
PREVIEW: Johnson & Johnson gains with investors eyeing tariffs ahead of earnings - TradingView
Jean Moore Johnson - News-Graphic.com
Johnson & Johnson's Earnings Preview: Anticipating Flat Revenues Amid Sector ChallengesNews and Statistics - IndexBox
Johnson Johnson (JNJ) 財務データ
収益
当期純利益
現金流量
EPS
1.28%
0.43%
大文字化:
|
ボリューム (24 時間):